Author

Chao‐Wen Cheng

Taipei Medical UniversityORCID 0000-0002-0466-6630Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Chih-Chieh Chang· 1 shared Seiji Mori· 1 shared Yoko K. Takada· 1 shared Yoshikazu TakadaiD· 1 shared Yukina Maekawa· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Chih-Chieh Chang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistryCellsPeer-reviewedFeb 7, 2024

FGF9, a potent mitogen, is a new ligand for integrin αvβ3, and the FGF9 mutant defective in integrin binding acts as an antagonist.

Chih-Chieh Chang, Yoko K. Takada, Chao‐Wen Cheng…·Yoshikazu Takada

This study identifies FGF9 as a new ligand for integrin αvβ3 and shows that a mutant defective in integrin binding acts as an antagonist by suppressing FGF9 signaling.

4 citations

humanproteomics

𝕏 PostBluesky